hrp0098fc15.2 | Late Breaking | ESPE2024
Roslan Amirul
, Román Rossana
, Avila Alejandra
, Said Daniela
, Baier Ingrid
, L. Brincks Erik
, Bruchey Aleksandra
, C. McKew John
, Duke Pitukcheewanont Pisit
, L. Johnson Michael
, Garner Terence
, O. Thorner Michael
, E. Clayton Peter
, Stevens Adam
, Cassorla Fernando
Background: Oral LUM-201 normalizes growth rates in moderate PGHD over 12 months (Phase 2 Trials: OraGrowtH210/OraGrowtH212) [FC-746 ESPE 2024]. In OraGrowtH212, GH profiles, based on 10-minute sampling over 12 hours (8am-8pm), showed significant increases in inter-pulse, pulsatile and total GH secretion in response to 1.6 and 3.2 mg/kg/day doses of LUM-201 over 6 months, with no difference between the doses [FC14.3, ESPE 2023].O...